SNX18P23

Across TCGA pan-cancer cohorts, SNX18P23 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated SNX18P23 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher SNX18P23 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX18P23 expression acts as an unfavorable survival marker, although some lineages such as SARC and LIHC show a favorable association.

OV, KIRP, and COAD are the cancer types where SNX18P23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.519	0.704	.001	126	view →
KIRP	OS	Tertile	All	0.315	0.729	<.001	85	view →
COAD	DFS	Tertile	All	0.324	0.698	<.001	54	view →
LUAD	DFS	Tertile	IV	0.194	0.734	<.001	54	view →
LUSC	OS	Tertile	All	0.211	0.542	<.001	54	view →
LGG	DFS	Tertile	All	0.530	0.754	<.001	48	view →
KICH	DFS	Quartile	All	0.351	0.950	<.001	43	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	39	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
PCPG	OS	Tertile	All	0.786	0.963	<.001	21	view →
SKCM	DFS	Tertile	III,IV	0.342	0.567	.005	19	view →
STAD	OS	Tertile	IV	0.126	0.585	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

SNX18P23–OV (OS)

Open the OV breakdown →